Regeneron Pharmaceuticals
REGN
REGN
631 hedge funds and large institutions have $20.4B invested in Regeneron Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 249 increasing their positions, 215 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
631
Holders Change
-26
Holders Change %
-3.96%
% of All Funds
13.86%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
55
Increased
249
Reduced
215
Closed
79
Calls
$497M
Puts
$560M
Net Calls
-$63M
Net Calls Change
+$76.7M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$166M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$86.4M |
| 3 |
Harris Associates
Chicago,
Illinois
|
+$62.9M |
| 4 |
BlackRock
New York
|
+$59.3M |
| 5 |
Two Sigma Investments
New York
|
+$35.3M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$128M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$126M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$116M |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$66.7M |
| 5 |
Goldman Sachs
New York
|
-$45.3M |
